{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T05:17:53Z","timestamp":1740115073036,"version":"3.37.3"},"reference-count":28,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002999","name":"Ministerie van Volksgezondheid, Welzijn en Sport","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002999","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.vaccine.2024.04.044","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T12:49:30Z","timestamp":1713876570000},"page":"3455-3460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections"],"prefix":"10.1016","volume":"42","author":[{"given":"Anne Jasmijn","family":"Sellies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mirjam J.","family":"Knol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hester E.","family":"de Melker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia C.J.L.","family":"Bruijning-Verhagen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemarijn R.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2024.04.044_b0005","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biochi.2020.09.018","article-title":"The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2","volume":"179","author":"Muralidar","year":"2020","journal-title":"Biochimie"},{"issue":"10","key":"10.1016\/j.vaccine.2024.04.044_b0010","doi-asserted-by":"crossref","first-page":"e1009928","DOI":"10.1371\/journal.ppat.1009928","article-title":"Induction of trained immunity by influenza vaccination - impact on COVID-19","volume":"17","author":"Debisarun","year":"2021","journal-title":"PLoS Pathog"},{"issue":"6","key":"10.1016\/j.vaccine.2024.04.044_b0015","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.ajic.2021.02.012","article-title":"Impact of the influenza vaccine on COVID-19 infection rates and severity","volume":"49","author":"Conlon","year":"2021","journal-title":"Am J Infect Control"},{"issue":"5","key":"10.1016\/j.vaccine.2024.04.044_b0020","article-title":"Association between Influenza Vaccination and Positive SARS-CoV-2 IgG and IgM Tests in the General Population of Katowice Region, Poland","volume":"9","author":"Kowalska","year":"2021","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.044_b0025","doi-asserted-by":"crossref","first-page":"11025","DOI":"10.1038\/s41598-021-90068-y","article-title":"Influenza vaccination and the risk of COVID-19 infection and severe illness in older adults in the United States","volume":"11","author":"Huang","year":"2021","journal-title":"Sci Rep"},{"issue":"9","key":"10.1016\/j.vaccine.2024.04.044_b0030","doi-asserted-by":"crossref","first-page":"e2233730","DOI":"10.1001\/jamanetworkopen.2022.33730","article-title":"Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older","volume":"5","author":"Hosseini-Moghaddam","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.044_b0035","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s10020-021-00317-z","article-title":"Heterologous vaccine interventions: boosting immunity against future pandemics","volume":"27","author":"Mar\u00edn-Hern\u00e1ndez","year":"2021","journal-title":"Mol Med"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.044_b0040","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.vaccine.2019.10.005","article-title":"Influenza vaccination and respiratory virus interference among Department of Defense personnel during the 2017\u20132018 influenza season","volume":"38","author":"Wolff","year":"2020","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.044_b0045","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.smim.2018.06.002","article-title":"Non-specific effects of vaccines: Current evidence and potential implications","volume":"39","author":"de Bree","year":"2018","journal-title":"Semin Immunol"},{"issue":"6","key":"10.1016\/j.vaccine.2024.04.044_b0050","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/s41577-020-0285-6","article-title":"Defining trained immunity and its role in health and disease","volume":"20","author":"Netea","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"10.1016\/j.vaccine.2024.04.044_b0055","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1631\/jzus.B2000479","article-title":"Comparison of COVID-19 and influenza characteristics","volume":"22","author":"Bai","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"10.1016\/j.vaccine.2024.04.044_b0060","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Griepprik. [Internet]. Available from: https:\/\/www.rivm.nl\/griep-griepprik\/griepprik. [Accessed January 6th 2022]."},{"key":"10.1016\/j.vaccine.2024.04.044_b0065","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Seasonal flu epidemic in the Netherlands. [Internet]. Available from: https:\/\/www.rivm.nl\/en\/news\/seasonal-flu-epidemic-in-netherlands#:\u223c:text=The%20flu%20epidemic%20usually%20starts,very%20occasionally%20in%20the%20Netherlands. [Accessed November 9th 2022]."},{"issue":"1","key":"10.1016\/j.vaccine.2024.04.044_b0070","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/EDE.0000000000001116","article-title":"The use of test-negative controls to monitor vaccine effectiveness: A systematic review of methodology","volume":"31","author":"Chua","year":"2020","journal-title":"Epidemiology"},{"issue":"36","key":"10.1016\/j.vaccine.2024.04.044_b0075","doi-asserted-by":"crossref","first-page":"4796","DOI":"10.1016\/j.vaccine.2017.07.003","article-title":"Basic principles of test-negative design in evaluating influenza vaccine effectiveness","volume":"35","author":"Fukushima","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2024.04.044_b0080","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Risk factors for COVID-19: CONTEST study. [Internet]. Available from: https:\/\/www.rivm.nl\/en\/coronavirus-covid-19\/research\/contest. [Accessed March 18th 2022]."},{"issue":"45","key":"10.1016\/j.vaccine.2024.04.044_b0085","doi-asserted-by":"crossref","first-page":"2200217","DOI":"10.2807\/1560-7917.ES.2022.27.45.2200217","article-title":"COVID-19 vaccine effectiveness against SARS-CoV-2 infection during the delta period, a nationwide study adjusting for chance of exposure, the netherlands, July to December 2021","volume":"27","author":"van Ewijk","year":"2022","journal-title":"Euro Surveill"},{"key":"10.1016\/j.vaccine.2024.04.044_b0090","unstructured":"Nederlandse Omroep Stichting. Mega-operatie van start: Nederland begonnen met vaccineren tegen corona. [Internet]. Available from: https:\/\/nos.nl\/artikel\/2363236-mega-operatie-van-start-nederland-begonnen-met-vaccineren-tegen-coronamet vaccineren tegen corona (nos.nl). [Accessed July 7th 2023]."},{"key":"10.1016\/j.vaccine.2024.04.044_b0095","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Deelname COVID-19-vaccinatie in Nederland. RIVM report: 16-11-2021. Figure 3."},{"key":"10.1016\/j.vaccine.2024.04.044_b0100","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Deelname COVID-19-vaccinatie in Nederland. RIVM report: 01-02-2022. Figure 4."},{"key":"10.1016\/j.vaccine.2024.04.044_b0105","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Informatie over het griepvaccin. [Internet]. Available from: https:\/\/www.rivm.nl\/griep-griepprik\/professionals\/vaccineren\/griepvaccin#:\u223c:text=Voor%20het%20griepseizoen%202021%2F22,griepvaccin%20tegen%203%20typen%20griepvirus. [Accessed November 18th 2022]."},{"year":"2022","series-title":"R: A language and environment for statistical computing","author":"R Core Team","key":"10.1016\/j.vaccine.2024.04.044_b0110"},{"issue":"4","key":"10.1016\/j.vaccine.2024.04.044_b0115","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1111\/irv.12839","article-title":"Absence of association between 2019\u201320 influenza vaccination and COVID-19: Results of the European I-MOVE-COVID-19 primary care project, March-August 2020","volume":"15","author":"Kissling","year":"2021","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.vaccine.2024.04.044_b0120","article-title":"Inactivated trivalent influenza vaccination is associated with lower mortality among patients with COVID-19 in Brazil. BMJ","author":"Fink","year":"2020","journal-title":"Evid Based Med"},{"key":"10.1016\/j.vaccine.2024.04.044_b0125","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.coi.2014.03.008","article-title":"Immunosenescence: Influenza vaccination and the elderly","volume":"29","author":"Haq","year":"2014","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.vaccine.2024.04.044_b0130","unstructured":"Rijksinstituut voor Volksgezondheid en Milieu. Vaccinatiegraad. [Internet]. Available from: https:\/\/www.rivm.nl\/griep-griepprik\/feiten-en-cijfers\/vaccinatiegraad#:\u223c:text=Van%20de%20mensen%20die%20in,huisarts%20gevaccineerd%20tegen%20de%20griep. [Accessed December 14th 2022]."},{"key":"10.1016\/j.vaccine.2024.04.044_b0135","unstructured":"Statistics Netherlands (CBS). Onderwijs, Cijfers, Maatschappij. [Internet]. Available from: https:\/\/longreads.cbs.nl\/trends18\/maatschappij\/cijfers\/onderwijs\/. [Accessed December 14th 2022]."},{"key":"10.1016\/j.vaccine.2024.04.044_b0140","unstructured":"NIVEL. Actuele weekcijfers aandoeningen - Surveillance. [Internet]. Available from: https:\/\/www.nivel.nl\/nl\/nivel-zorgregistraties-eerste-lijn\/actuele-weekcijfers-aandoeningen-surveillance#Nivel-Service-Bulletins. [Accessed November 17th 2022]."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X24004687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T20:56:07Z","timestamp":1716843367000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X24004687"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":28,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S0264410X24004687"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2024.04.044","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier India Pvt Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}